Can a new tool better measure opioid withdrawal?

NCT ID NCT07094672

First seen Aug 14, 2026 ยท Last updated Aug 14, 2026

Summary

This study aims to develop and validate a new questionnaire to measure opioid withdrawal symptoms. Researchers will work with people who have experienced opioid withdrawal to identify all possible symptoms and refine the tool through interviews and testing. The goal is to create a standardized measure that can be used in clinical trials and practice to improve withdrawal management.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this could provide a standardized, FDA-qualified tool to measure opioid withdrawal, improving treatment and care for people with opioid use disorder.
What could go wrong
This is an early-stage study with a small number of participants, so the tool may not capture all experiences or be widely applicable. Further validation is needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kahlert Institute for Addiction Medicine

    Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.